We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$77.6B
AUM Growth
+$5.19B
(+7.2%)
Cap. Flow
+$4.38B
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
15.11%
Holding
3,002
New
251
Increased
1,435
Reduced
1,132
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$243M |
| 3 |
Tesla
TSLA
|
+$188M |
| 4 |
Adobe
ADBE
|
+$159M |
| 5 |
Infosys
INFY
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$143M |
| 2 |
Cigna
CI
|
+$133M |
| 3 |
Delta Air Lines
DAL
|
+$121M |
| 4 |
Walt Disney
DIS
|
+$120M |
| 5 |
Cisco
CSCO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.8% |
| 2 | Financials | 15.9% |
| 3 | Healthcare | 13.33% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 11.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Vir Biotechnology
VIR
$1.5B
| $90K | ﹤0.01% |
12,260
-4,662
| -28% | -$36.8K |
|
|
VCSA
2777
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $88.4K | ﹤0.01% |
18,047
-2,266
| -11% | -$7.26K |
|
2778
Standard BioTools
LAB
$314M
| $87.8K | ﹤0.01% |
50,187
-36,987
| -42% | -$68.9K |
|
2779
Nordic American Tanker
NAT
$1.31B
| $87.6K | ﹤0.01% |
35,032
-257,623
| -88% | -$791K |
|
2780
Lifezone Metals
LZM
$367M
| $85.7K | ﹤0.01% |
+12,338
| New | +$82.6K |
|
2781
Information Services Group
III
$250M
| $82K | ﹤0.01% |
24,563
+1,855
| +8% | +$6.2K |
|
|
ADAM
2782
Adamas Trust
ADAM
$920M
| $81.6K | ﹤0.01% |
13,464
-3,627
| -21% | -$21.3K |
|
|
CMRC
2783
Commerce.com Inc Series 1
CMRC
$183M
| $80.1K | ﹤0.01% |
+13,091
| New | +$81.9K |
|
2784
Applied Digital
APLD
$8.58B
| $78.3K | ﹤0.01% |
+10,253
| New | +$85.2K |
|
2785
ADC Therapeutics
ADCT
$151M
| $78.3K | ﹤0.01% |
39,362
+17,255
| +78% | +$45.2K |
|
2786
Pyxis Oncology
PYXS
$177M
| $78.1K | ﹤0.01% |
+50,080
| New | +$144K |
|
|
LPRO
2787
DELISTED
Open Lending Corp
LPRO
| $76.8K | ﹤0.01% |
12,871
+1,890
| +17% | +$11.3K |
|
|
AEVA
2788
Aeva Technologies
AEVA
$1.69B
| $76.7K | ﹤0.01% |
16,142
+1,880
| +13% | +$7.61K |
|
|
GPMT
2789
Granite Point Mortgage Trust
GPMT
$59.8M
| $76.2K | ﹤0.01% |
+27,296
| New | +$85.9K |
|
2790
Expensify
EXFY
$214M
| $73.5K | ﹤0.01% |
21,950
-166,747
| -88% | -$448K |
|
2791
NovaGold Resources
NG
$3.36B
| $71.4K | ﹤0.01% |
21,451
+4,588
| +27% | +$16.2K |
|
2792
Lexeo Therapeutics
LXEO
$379M
| $70.5K | ﹤0.01% |
+10,710
| New | +$84.4K |
|
2793
ALX Oncology
ALXO
$270M
| $70.1K | ﹤0.01% |
41,985
+13,479
| +47% | +$20.7K |
|
2794
Bit Digital
BTBT
$464M
| $64.9K | ﹤0.01% |
22,139
+2,169
| +11% | +$8.53K |
|
2795
Traeger
COOK
$174M
| $63.3K | ﹤0.01% |
530
+96
| +22% | +$14.7K |
|
2796
VTEX
VTEX
$672M
| $63.2K | ﹤0.01% |
+10,727
| New | +$70.3K |
|
2797
Sibanye-Stillwater
SBSW
$7.52B
| $61.6K | ﹤0.01% |
+18,661
| New | +$78.5K |
|
2798
Skye Bioscience
SKYE
$18.5M
| $61.3K | ﹤0.01% |
+21,653
| New | +$90.5K |
|
|
ETWO
2799
DELISTED
E2open Parent Holdings
ETWO
| $60.3K | ﹤0.01% |
22,682
-6,450
| -22% | -$20.3K |
|
2800
PLAYSTUDIOS Inc
MYPS
$81.1M
| $59.1K | ﹤0.01% |
31,756
+8,768
| +38% | +$15K |
|
Similar funds
VGA
AQR Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, AQR Capital Management held 3,002 positions worth $77.6B, up 7.2% from $72.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $4.38B of net new capital in Q4 2024, opening 251 new positions and adding to 1,435 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $143M trimmed.
- AQR Capital Management's largest Q4 2024 buy was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.
- AQR Capital Management added most to Apple in Q4 2024, an estimated $523M increase.
- AQR Capital Management's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $143M.
- AQR Capital Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $5.41M.
- AQR Capital Management's ten largest holdings make up 15% of its $77.6B portfolio in Q4 2024.
- AQR Capital Management opened 251 new positions and closed 141 in Q4 2024.
- AQR Capital Management's portfolio value rose 7.2% quarter-over-quarter to $77.6B.
Based on AQR Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.